THE ECCLESBOURNE PRACTICE — All Prescriptions & Medications
Practice Code: F86018 | LONDON, E17 9DP
Over the last 12 months, THE ECCLESBOURNE PRACTICE prescribed 169,827 items across 560 different medications at a total cost of £1,701,053 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Amiloride hydrochloride | 10 | 840 | £410 | -60.3% ▼ |
| Inclisiran | 10 | 10 | £520 | -20.6% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 10 | 360 | £513 | -9.4% ▼ |
| Zonisamide | 10 | 1,792 | £1.0K | -77.1% ▼ |
| Quinine bisulfate | 10 | 364 | £64 | -74.2% ▼ |
| Empagliflozin/metformin | 10 | 1,008 | £626 | -80.8% ▼ |
| Medroxyprogesterone acetate | 10 | 552 | £114 | -73.9% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 10 | 123.0K | £4.0K | -6.0% ▼ |
| Pyridostigmine bromide | 10 | 2,000 | £153 | -41.6% ▼ |
| Pimecrolimus | 10 | 330 | £204 | -40.9% ▼ |
| Fluorouracil (Sunscreen) | 10 | 400 | £313 | -72.5% ▼ |
| Lidocaine | 10 | 275 | £179 | -13.0% ▼ |
| 10 | 198 | £64 | -66.5% ▼ | |
| 10 | 210 | £476 | -36.3% ▼ | |
| 10 | 215 | £42 | -65.5% ▼ | |
| 10 | 640 | £24 | -40.8% ▼ | |
| 10 | 1,400 | £228 | -74.6% ▼ | |
| 10 | 1,000 | £309 | +95.0% ▲ | |
| 10 | 300 | £1.5K | -13.9% ▼ | |
| 10 | 570 | £1.9K | -14.9% ▼ | |
| 10 | 570 | £1.3K | -29.3% ▼ | |
| 10 | 240 | £1.7K | -21.1% ▼ | |
| Temazepam | 11 | 77 | £69 | -80.8% ▼ |
| Pizotifen malate | 11 | 588 | £28 | -86.7% ▼ |
| Testosterone undecanoate | 11 | 11 | £958 | -56.7% ▼ |
| Anastrozole | 11 | 616 | £23 | -87.9% ▼ |
| Calamine | 11 | 2,100 | £16 | +45.1% ▲ |
| Diclofenac sodium | 11 | 550 | £400 | -54.1% ▼ |
| 11 | 400 | £1.2K | +71.3% ▲ | |
| 11 | 900 | £1.4K | -37.6% ▼ | |
| 11 | 275 | £60 | -73.0% ▼ | |
| 11 | 22 | £302 | -20.3% ▼ | |
| Diltiazem hydrochloride | 12 | 360 | £145 | +159.1% ▲ |
| Bempedoic acid | 12 | 672 | £1.3K | -63.4% ▼ |
| Dienogest | 12 | 868 | £604 | +65.7% ▲ |
| Powder extensively hydrolysed formula (0913101) | 12 | 17.2K | £476 | -83.3% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 12 | 33.4K | £975 | -54.8% ▼ |
| Tube feed 1 kcal/ml peptide based (0914041) | 12 | 353.0K | £11.5K | +35.0% ▲ |
| Prednisolone acetate | 12 | 160 | £56 | -34.2% ▼ |
| Azelastine hydrochloride | 12 | 144 | £110 | +1.0% vs avg |
| Aluminium chloride | 12 | 560 | £116 | +48.0% ▲ |
| 12 | 720 | £1.5K | +44.1% ▲ | |
| 12 | 30 | £370 | +535.2% ▲ | |
| 12 | 1,670 | £345 | -70.7% ▼ | |
| Simeticone | 13 | 1,289 | £80 | +137.1% ▲ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 13 | 756 | £348 | -20.5% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 13 | 840 | £483 | -17.8% ▼ |
| Dosulepin hydrochloride | 13 | 1,848 | £381 | -77.0% ▼ |
| Naratriptan hydrochloride | 13 | 150 | £50 | -50.3% ▼ |
| Brivaracetam | 13 | 364 | £844 | -61.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.